Algorae Pharmaceuticals Limited Stock price
Equities
1AI
AU0000296022
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 AUD | 0.00% | +11.11% | 0.00% |
Mar. 08 | Algorae Pharmaceuticals Nears Launch of Drug Discovery Platform | MT |
Feb. 28 | Algorae Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2022 | 3.4K 2.21K | Sales 2023 | 42.02K 27.28K | Capitalization | 23.4M 15.2M |
---|---|---|---|---|---|
Net income 2022 | -1M -649K | Net income 2023 | -2M -1.3M | EV / Sales 2022 | 1,775 x |
Net cash position 2022 | 4.24M 2.75M | Net cash position 2023 | 4.11M 2.67M | EV / Sales 2023 | 459 x |
P/E ratio 2022 |
-3.58
x | P/E ratio 2023 |
-9.38
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 57.91% |
1 week | +11.11% | ||
1 month | -9.09% | ||
3 months | -9.09% | ||
6 months | -33.33% |
Managers | Title | Age | Since |
---|---|---|---|
Daya Uka
DFI | Director of Finance/CFO | - | 15-12-31 |
James Mckenna
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-18 |
Chief Operating Officer | - | 21-12-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Hainsworth
CHM | Chairman | 50 | 22-10-30 |
Bradley Dilkes
BRD | Director/Board Member | 39 | 22-10-30 |
Bradley Latham
BRD | Director/Board Member | 62 | 23-07-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.01 | 0.00% | 115 018 |
24-03-27 | 0.01 | +11.11% | 421,600 |
24-03-26 | 0.009 | 0.00% | 500,933 |
24-03-25 | 0.009 | 0.00% | 102,708 |
24-03-22 | 0.009 | 0.00% | 1,011,011 |
Delayed Quote Australian S.E., March 28, 2024 at 01:10 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 10.84M | |
+2.56% | 108B | |
+10.02% | 104B | |
+7.48% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |